In the News
ICON experts frequently author or contribute to industry trade press.
Filter media articles by either clicking within the ‘Category’ drop-down list, or begin typing which will automatically match to the nearest available category.
-
Identifying integrated digital platforms designed for a decentralised future
Matt Harrington, VP of Connected Health Technology Solutions, explores how the use of digital platforms and associated services can contribute to more adaptable, accessible and efficient clinical trials.
-
Patient centricity in insulin injection: Using technology to improve self-administration
David T. Novotny, General Manager & Global Head of ICON’s Medical Device and Diagnostic Research business unit, considers the current and future developments in injection technology.
-
Putting patients at the heart of clinical trials
Scott Palmese, Senior Director, Accellacare Site Network, shares his insights on optimising the patient experience within clinical trials, and the ramifications of the COVID-19 pandemic (page 14).
-
Embedded blended solutions - A new way to optimise clinical trial portfolio delivery
Insights on the options available to pharma companies when delivering their clinical trial portfolios.
This article is taken from European Pharmaceutical Contractor February 2022, pages 60-63 Samedan Ltd.
-
-
Triangle's CRO industry saw a flurry of M&A activity over past year
This article provides an overview of the mergers and acquisition activity across 2021 that have involved CROs based or heavily present in the North Carolina Triangle, which includes ICON’s $12bn acquisition of PRA Health Sciences.
-
Using cross-functional teams to develop a product's value story
Experts from the Commercial Solutions team discuss how essential a data-driven strategy is to successfully communicate a brand’s value proposition in a competitive market.
-
ICON plc (ICLR) Q4 earnings meet estimates
This article summarises ICON’s quarterly and 2021 year-end financial results.
-
So what sectors had the most M&A activity?
This article shares how the medical and biotech sectors have dominated the mergers & acquisitions (M&A) landscape and mentions ICON’s acquisition of PRA Health Sciences. (registration required)
-
A ‘banner year’ for M&A activity across Ireland
This article provides an overview of the mergers and acquisition activity that took place in Ireland across 2021. This includes ICON’s $12bn acquisition of PRA Health Sciences as one of the “big deals of 2021”. (Registration required)
